STEPS to Success: Simplicity and Safety

Dr. Cynthia Manabat talks about her S.T.E.P.S. to success in managing type 2 diabetes. S.T.E.P.S. stands for safety, tolerability, efficacy, personalization and simplicity. She will discuss the clinical data and real-world evidence supporting linagliptin’s proven consistent efficacy and safety across a broad range of patients. Furthermore, the different renal excretion rate of DPP4i will be discussed and how the lowest renal excretion rate of linagliptin truly offers no dose adjustment for its patients.

Estimated time of Completion: 25 mins